Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Exelixis Raises FY2025 Sales Guidance from $2.250B-$2.350B to $2.300B-$2.350B vs $2.320B Est

Author: Benzinga Newsdesk | November 04, 2025 04:11pm

Exelixis (NASDAQ:EXEL) raises FY2025 sales outlook from $2.250 billion-$2.350 billion to $2.300 billion-$2.350 billion vs $2.320 billion estimate.

Posted In: EXEL